Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R LAW

Showing results (151-160 of 545) with videos related to

Pageof 55
Sort By:
BMJ (Clinical Research Ed.)|September 7, 2012
Drug development: Innovation or imitation deficit?Steven G Morgan, Colleen M Cunningham, Michael R Law
Cardiovascular Research|January 1, 1990
Insulin and beta adrenergic effects during endotoxin shock: in vivo myocardial interactionsW R Law, M P McLane, R M Raymond
Lancet (London, England)|March 14, 1992
Screening for osteoporosisM R Law, N J Wald, T W Meade
Psychiatric Services (Washington, D.C.)|May 3, 2008
Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursementsMichael R Law, Dennis Ross-Degnan, Stephen B Soumerai
British Journal of Clinical Pharmacology|August 31, 2006
Calcium channel blockers and headacheM R Law, J K Morris, N J Wald
Healthcare Policy = Politiques De Sante|August 24, 2013
Cost-control mechanisms in Canadian private drug plansJillian Kratzer, Kimberlyn McGrail, Erin Strumpf, et al.
BMJ (Clinical Research Ed.)|February 5, 1994
Assessing possible hazards of reducing serum cholesterolM R Law, S G Thompson, N J Wald
Cardiovascular Research|February 1, 1991
Influence of adenosine on the stimulatory effect of isoprenaline and insulin on myocardial contractility in vivoW R Law, P J Carney, M P McLane
Diabetes|June 1, 1988
Adenosine is required for myocardial insulin responsiveness in vivoW R Law, M P McLane, R M Raymond
Circulatory Shock|August 1, 1989
Adenosine restores myocardial responsiveness to insulin during acute endotoxin shock in vivoW R Law, M P McLane, R M Raymond
Pageof 55

Showing results (151-160 of 545) with videos related to

Sort By:
Pageof 55
BMJ (Clinical Research Ed.)|September 7, 2012
Drug development: Innovation or imitation deficit?Steven G Morgan, Colleen M Cunningham, Michael R Law
Cardiovascular Research|January 1, 1990
Insulin and beta adrenergic effects during endotoxin shock: in vivo myocardial interactionsW R Law, M P McLane, R M Raymond
Lancet (London, England)|March 14, 1992
Screening for osteoporosisM R Law, N J Wald, T W Meade
Psychiatric Services (Washington, D.C.)|May 3, 2008
Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursementsMichael R Law, Dennis Ross-Degnan, Stephen B Soumerai
British Journal of Clinical Pharmacology|August 31, 2006
Calcium channel blockers and headacheM R Law, J K Morris, N J Wald
Healthcare Policy = Politiques De Sante|August 24, 2013
Cost-control mechanisms in Canadian private drug plansJillian Kratzer, Kimberlyn McGrail, Erin Strumpf, et al.
BMJ (Clinical Research Ed.)|February 5, 1994
Assessing possible hazards of reducing serum cholesterolM R Law, S G Thompson, N J Wald
Cardiovascular Research|February 1, 1991
Influence of adenosine on the stimulatory effect of isoprenaline and insulin on myocardial contractility in vivoW R Law, P J Carney, M P McLane
Diabetes|June 1, 1988
Adenosine is required for myocardial insulin responsiveness in vivoW R Law, M P McLane, R M Raymond
Circulatory Shock|August 1, 1989
Adenosine restores myocardial responsiveness to insulin during acute endotoxin shock in vivoW R Law, M P McLane, R M Raymond
Pageof 55